10 ml Solution

Contains: Sodium chloride, benzyl alcohol, MAF-Ultra peptide 2,000 mcg (20,000,000 ng), BAS, Sterile water.

The Structure of MAF-ULTRA provides macrophage activation which cannot be inactivated by deglycosylation.

MAF-ULTRA may help promoting an analgesic effect to treat pain resulting from any cause.

MAF-ULTRA may help promoting effects the immune system by activation of cells of the monocyte/macrophage lineage and/or other lymphoid cells.

MAF-ULTRA may help promoting macrophage activation within minutes, which is much faster than that of traditional cytokines which take five hours.

MAF-ULTRA may help activating and enhancing the immune response. MAF-ULTRA Inhibits the immunosuppressive responses and enhances the effector T cell responses.

MAF-ULTRA may help enhancing the efficacy of effector T cell function, by increasing the ratio of effector T cells to regulatory T cells within the tumor and the tumor microenvironment.

MAF-ULTRA may help suppressing the population of regulatory T cells within the tumor and the tumor microenvironment and alters the cytokine profile of the subject to enhance to efficacy of effector T cell function, by inducing a several-fold increase of IL-2, IL-12p70, IL-21, IL-27, TNFa, and IFNy in serum. Increase in serum levels of these cytokines occur within 4 hours.

MAF-ULTRA Promotes a broad expansion of immune cell populations not matched by Gc-MAF.